PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹660 Cr | ₹257 Cr | ₹356 Cr | ₹667 Cr | ₹427 Cr |
What is the latest Cash Flow from Operating Activities ratio of PFIZER ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹660 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹356 Cr |
| Mar2022 | ₹667 Cr |
| Mar2021 | ₹427 Cr |
How is Cash Flow from Operating Activities of PFIZER Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹660 Cr | 156.87 | |
| Mar2024 | ₹257 Cr | -27.79 | |
| Mar2023 | ₹356 Cr | -46.68 | |
| Mar2022 | ₹667 Cr | 56.10 | |
| Mar2021 | ₹427 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,493.4 Cr | -0.4% | -7.3% | 13.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -0.4% |
-7.3% |
13.3% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses